Haim Aesthetics boasts one of the most extensive portfolios of clinically proven flagship brands in dermatology, including Eloquence, LeVair, ExoVair, Elotox, and others in the Injectable Aesthetics category.
To ensure long-term sustainable growth, Haim Aesthetics capitalizes on its cutting-edge science and innovation capabilities. The company has successfully enhanced its scientific differentiation and advanced its product pipeline, featuring two clinically de-risked biologics with blockbuster potential: a first-in-class biologic that combines two types of hyaluronic acids with succinic acids and a next-generation liquid injectable aesthetic enriched with high levels of PDRN and PN
Worldwide Reach with Exceptional
Omni-Channel Execution
Haim Aesthetics operates in over 50 countries, strategically positioning itself within appealing and consumer-focused segments of the dermatology market, supported by strong growth prospects and robust fundamentals. Our extensive global presence offers significant opportunities for expansion, particularly as we continue to penetrate rapidly growing regions. By leveraging our synergistic flagship brands, we are well-equipped to capitalize on these emerging markets and drive sustained growth.
Industry-Leading Education
and Support Services
Haim Aesthetics offers unique, value-driven platforms that encompass industry-leading education, scientific engagement, and comprehensive service offerings, all of which enhance market penetration and foster loyalty across our portfolio. By focusing on derma-tology-centric healthcare professionals within our integrated dermatology strategy, Haim Aesthetics demonstrates its commitment to the field by providing extensive training and establishing itself as a premier provider of medical education for aesthetic practices worldwide, while also maintaining a prominent presence at global dermatology congresses.
